Stay updated on Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision number advances from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-06T18:54:01.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The record history now shows a new revision v3.7.0 added and the previous revision v3.6.6 removed, reflecting an updated version of the study record.
    Difference
    0.1%
    Check dated 2026-09-15T20:30:46.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The revision tag in the study history updated from v3.6.5 to v3.6.6. This indicates a new internal revision entry has been posted to the record.
    Difference
    0.1%
    Check dated 2026-09-01T18:01:13.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.5 has been added to the study record history. The previous revision entry v3.6.4 has been removed.
    Difference
    0.1%
    Check dated 2026-08-11T08:09:12.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 was added to the study record history, replacing the previous v3.6.3 entry. This reflects a minor backend page update and does not change study data or reported results.
    Difference
    0.1%
    Check dated 2026-07-28T03:07:00.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Revision: v3.6.3 replaces v3.6.2 in the history. This reflects a platform update to the page.
    Difference
    0.1%
    Check dated 2026-07-06T16:29:17.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in Relapsed AML/MDS Post Allo-HCT Clinical Trial page.